{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:47:27Z","timestamp":1773053247145,"version":"3.50.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.hfc.2009.02.003","type":"journal-article","created":{"date-parts":[[2009,6,28]],"date-time":"2009-06-28T04:36:23Z","timestamp":1246163783000},"page":"369-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular Magnetic Resonance in the Evaluation of Hypertrophic and Infiltrative Cardiomyopathies"],"prefix":"10.1016","volume":"5","author":[{"given":"Rory","family":"O'Hanlon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dudley J.","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2009.02.003_bib1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2009.02.003_bib2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/01.CIR.92.5.1336","article-title":"Recent advances in the molecular genetics of hypertrophic cardiomyopathy","volume":"92","author":"Marian","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib3","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/hc4201.097429","article-title":"New concepts in hypertrophic cardiomyopathy, part I","volume":"104","author":"Roberts","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.hfc.2009.02.003_bib6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib7","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2009.02.003_bib10","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.ehj.2004.06.040","article-title":"Society for Cardiovascular Magnetic Resonance; Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report","volume":"25","author":"Pennell","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2009.02.003_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/10976640600737383","article-title":"Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy","volume":"8","author":"Schulz-Menger","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2009.02.003_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2008.04.047","article-title":"Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"52","author":"Olivotto","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.amjcard.2007.05.061","article-title":"Right ventricular involvement in hypertrophic cardiomyopathy","volume":"100","author":"Maron","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jmri.21381","article-title":"Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy","volume":"28","author":"Abdel-Aty","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.hfc.2009.02.003_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00001573-199405000-00011","article-title":"Risk stratification in hypertrophic cardiomyopathy","volume":"9","author":"Vassalli","year":"1994","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib17","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib18","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib19","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jacc.2006.02.049","article-title":"The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators","volume":"47","author":"Reynolds","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2009.02.003_bib21","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0735-1097(99)00492-1","article-title":"Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death","volume":"35","author":"Shirani","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young. Pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hfc.2009.02.003_bib24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heart.84.5.476","article-title":"Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease","volume":"84","author":"Varnava","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2009.02.003_bib25","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","article-title":"Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"40","author":"Choudhury","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib26","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0002-9149(92)90771-P","article-title":"Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy","volume":"70","author":"Kuribayashi","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.RES.56.3.436","article-title":"Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing","volume":"56","author":"Ursell","year":"1985","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2009.02.003_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.CIR.88.3.915","article-title":"Slow conduction in the infarcted human heart: \u201czigzag\u201d course of activation","volume":"88","author":"de Bakker","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib29","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1161\/hc5001.100833","article-title":"Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis","volume":"104","author":"Kawara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0008-6363(02)00271-7","article-title":"Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis","volume":"54","author":"Anyukhovsky","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2009.02.003_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/hrt.44.4.433","article-title":"Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis","volume":"44","author":"St John Sutton","year":"1980","journal-title":"Br Heart J"},{"key":"10.1016\/j.hfc.2009.02.003_bib32","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10554-007-9209-9","article-title":"Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy with and without sustained ventricular tachycardia","volume":"24","author":"Dimitrow","year":"2008","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2009.02.003_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10554-008-9292-6","article-title":"Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study","volume":"24","author":"Kwon","year":"2008","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2009.02.003_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","article-title":"Relevance of coronary microvascular flow impairment to long-term remodelling and systolic dysfunction in hypertrophic cardiomyopathy","volume":"47","author":"Olivotto","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiol.2261011874","article-title":"First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene","volume":"226","author":"Sipola","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.hfc.2009.02.003_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2463\/mrms.2.61","article-title":"First-pass myocardial perfusion and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI","volume":"2","author":"Matsunaka","year":"2003","journal-title":"Magn Reson Med Sci"},{"key":"10.1016\/j.hfc.2009.02.003_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.nuclcard.2006.05.018","article-title":"Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study","volume":"13","author":"Knaapen","year":"2006","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib42","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2967\/jnumed.107.050138","article-title":"Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy","volume":"49","author":"Sotgia","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmri.20473","article-title":"Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI","volume":"23","author":"Tseng","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.hfc.2009.02.003_bib45","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib46","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.hfc.2009.02.003_bib47","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","article-title":"Survival in beta thalassaemia major in the UK: data from the UK Thalassaemia Register","volume":"355","author":"Modell","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2009.02.003_bib48","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.103.4.1276","article-title":"Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassaemia major","volume":"103","author":"Wacker","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2009.02.003_bib49","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (\u2217) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"21","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2009.02.003_bib50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10976640600698155","article-title":"Myocardial iron loading in patients with thalassemia major on deferoxamine chelation","volume":"8","author":"Tanner","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2009.02.003_bib51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2\u2217 cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hfc.2009.02.003_bib52","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassemia","volume":"360","author":"Anderson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2009.02.003_bib53","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomised controlled trial of deferiprone or deferoxamine in beta-thalassemia major in patients with asymptomatic myocardial siderosis","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hfc.2009.02.003_bib54","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2009.02.003_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-10-12","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with severe left ventricular dysfunction","volume":"10","author":"Tanner","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.hfc.2009.02.003_bib56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Falling mortality and changing causes of death in thalassaemia major: data from the UK Thalassaemia Register and possible contribution from T2\u2217 cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2009.02.003_bib57","first-page":"1187","article-title":"Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980\u20132004","volume":"91","author":"Telfer","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.hfc.2009.02.003_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ajcp\/99.1.39","article-title":"Progressive hemochromatosis cardiomyopathy despite reversal of iron deposition after liver transplantation","volume":"99","author":"Westra","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.hfc.2009.02.003_bib59","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group II)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib60","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoidosis: a clinico-pathological study of 84 in selected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib61","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","article-title":"A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy","volume":"150","author":"Ardehali","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2009.02.003_bib62","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0272-5231(05)70419-6","article-title":"Nuclear imaging: 67 Gallium, 201 thallium, 18 F labeled fluoro-2 deoxy-D glucose position emission tomography","volume":"18","author":"Mana","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/000331979004100711","article-title":"Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms?","volume":"41","author":"Kinney","year":"1990","journal-title":"Angiology"},{"key":"10.1016\/j.hfc.2009.02.003_bib64","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00003072-199406000-00012","article-title":"Myocardial involvement in patients with sarcoidosis: an analysis of 75 patients","volume":"19","author":"Hirose","year":"1994","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.72.1.27","article-title":"The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease","volume":"72","author":"Bulkley","year":"1977","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2009.02.003_bib66","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2214\/ajr.185.1.01850110","article-title":"Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionucleotide imaging","volume":"185","author":"Tadamura","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.hfc.2009.02.003_bib67","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/crad.1999.0081","article-title":"MR findings of myocardial sarcoidosis","volume":"55","author":"Matsuki","year":"2000","journal-title":"Clin Radiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2003.07.024","article-title":"Sarcoid heart disease: clinical course and treatment","volume":"97","author":"Bargout","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib70","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1378\/chest.122.6.1895","article-title":"Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study","volume":"122","author":"Vignaux","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2009.02.003_bib71","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1378\/chest.128.3.1629","article-title":"The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2009.02.003_bib72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0954-6111(98)90522-4","article-title":"Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment","volume":"92","author":"Doherty","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib73","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/archinte.166.17.1805","article-title":"Amyloidosis and the heart: a comprehensive review","volume":"166","author":"Shah","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9149(97)89403-9","article-title":"Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis","volume":"77","author":"Dubrey","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib75","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0735-1097(84)80436-2","article-title":"Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities","volume":"3","author":"Falk","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib77","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1460-9592.2001.01228.x","article-title":"Holter monitoring in AL amyloidosis: prognostic implications","volume":"24","author":"Palladini","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib78","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib79","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib80","first-page":"10","article-title":"Endomyocardial fibrosis in Uganda","volume":"25","author":"Davies","year":"1948","journal-title":"East Afr Med J"},{"key":"10.1016\/j.hfc.2009.02.003_bib81","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1161\/01.CIR.0000157399.96408.36","article-title":"Visualisation of endomyocardial fibrosis by delayed enhancement magnetic resonance imaging","volume":"111","author":"Cury","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib82","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2004.09.014","article-title":"Pediatric hypereosinophilic syndrome (HES) differs from adult HES","volume":"46","author":"Katz","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.hfc.2009.02.003_bib83","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis, and periarteritis nodosa","volume":"27","author":"Churg","year":"1951","journal-title":"Am J\u00a0Pathol"},{"key":"10.1016\/j.hfc.2009.02.003_bib84","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/thorax.55.9.805","article-title":"Churg-Strauss syndrome associated with montelukast therapy","volume":"55","author":"Tuggey","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.hfc.2009.02.003_bib85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1099-1557(199905\/06)8:3<179::AID-PDS414>3.0.CO;2-K","article-title":"Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia, and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies","volume":"8","author":"Martin","year":"1999","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.hfc.2009.02.003_bib86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1054-8807(02)00157-6","article-title":"Churg-Strauss syndrome and sudden cardiac death","volume":"12","author":"Val-Bernal","year":"2003","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.hfc.2009.02.003_bib87","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/hrt.77.6.576","article-title":"Coronary involvement in the Churg-Strauss syndrome","volume":"77","author":"Hellemans","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2009.02.003_bib88","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/art.1780371214","article-title":"Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients","volume":"37","author":"Abu-Shakra","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.hfc.2009.02.003_bib89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine"},{"key":"10.1016\/j.hfc.2009.02.003_bib90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome","volume":"63","author":"Lanham","year":"1984","journal-title":"Medicine"},{"key":"10.1016\/j.hfc.2009.02.003_bib91","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2004-836145","article-title":"Churg-Strauss syndrome","volume":"25","author":"Guillevin","year":"2004","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib92","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.amjcard.2005.11.088","article-title":"Cardiac involvement in the Churg-Strauss syndrome","volume":"97","author":"Pela","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib93","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00392-006-0364-0","article-title":"Rapid progressive eosinophilic cardiomyopathy in a patient with Churg-Strauss syndrome (CSS)","volume":"95","author":"Rosenberg","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib94","first-page":"27","article-title":"Control of Chagas disease","volume":"81","author":"World Health Organization","year":"1991","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"1","key":"10.1016\/j.hfc.2009.02.003_bib95","first-page":"553","article-title":"Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity","volume":"46","author":"Rochitte","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib96","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"Marin-Neto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib97","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijcard.2007.06.012","article-title":"Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy","volume":"127","author":"Nunes","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib98","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1161\/01.CIR.0000050691.73932.CB","article-title":"Myocardial fibrosis in glycogen storage disease type III","volume":"107","author":"Moon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib99","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","article-title":"Constitutively active AMP-kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy","volume":"109","author":"Arad","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2009.02.003_bib100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib101","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nmd.2005.12.004","article-title":"A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis","volume":"16","author":"Laforet","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.hfc.2009.02.003_bib102","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2009.02.003_bib103","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.02.003_bib104","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium","volume":"23","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2009.02.003_bib105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","article-title":"Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study","volume":"51","author":"Takenaka","year":"2008","journal-title":"J Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib106","first-page":"98","article-title":"End-stage cardiac manifestations and autopsy findings in patients with cardiac Fabry disease","volume":"43","author":"Teraguchi","year":"2004","journal-title":"J Cardiol"},{"key":"10.1016\/j.hfc.2009.02.003_bib107","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease:\u00a0a randomised, double blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2009.02.003_bib108","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","article-title":"Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy","volume":"97","author":"Beer","year":"2006","journal-title":"Am J Cardiol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155171360900018X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155171360900018X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:38:27Z","timestamp":1761554307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155171360900018X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S155171360900018X"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2009.02.003","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Magnetic Resonance in the Evaluation of Hypertrophic and Infiltrative Cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2009.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}